Birdwatch Note
2024-10-30 00:04:32 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
接種後有害事象の任意の報告頻度は報道や https://www.sciencedirect.com/science/article/pii/S1054139X13004874 販売後の時間等 https://www.mdpi.com/2076-393X/8/1/117 多様な影響を受けCDCは実際の頻度の評価には使えないと明示しています https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html#:~:text=VAERS%20is%20the%20nation's%20early,make%20sure%20vaccines%20are%20safe. 副反応疑い報告でも同じコロナワクチンでも最初の4ロットと比べると22年の最初の4ロットでは全副反応疑い報告率は約百分の1まで低下しています。(下記88P https://www.mhlw.go.jp/content/10601000/001161404.pdf 特に死亡に関しては、日本人の死亡の1~2割程が死期が近い事が予期されてなかった突然の内因死であり http://www.jsomt.jp/journal/pdf/062010057.pdf 旧来型のワクチンでも一定の接種直後死亡記録は発生します。 https://www.ajpmonline.org/article/S0749-3797(13)00225-0/fulltext また条件が違うとはいえ新型インフルワクチンでも同様の頻度の疑い報告が発生しています。 https://www.yakuji.co.jp/entry21054.html
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1851384548166393961
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1851414848078495997
- noteId - 1851414848078495997
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1730246672063
- tweetId - 1851384548166393961
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 接種後有害事象の任意の報告頻度は報道や https://www.sciencedirect.com/science/article/pii/S1054139X13004874 販売後の時間等 https://www.mdpi.com/2076-393X/8/1/117 多様な影響を受けCDCは実際の頻度の評価には使えないと明示しています https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html#:~:text=VAERS%20is%20the%20nation's%20early,make%20sure%20vaccines%20are%20safe. 副反応疑い報告でも同じコロナワクチンでも最初の4ロットと比べると22年の最初の4ロットでは全副反応疑い報告率は約百分の1まで低下しています。(下記88P https://www.mhlw.go.jp/content/10601000/001161404.pdf 特に死亡に関しては、日本人の死亡の1~2割程が死期が近い事が予期されてなかった突然の内因死であり http://www.jsomt.jp/journal/pdf/062010057.pdf 旧来型のワクチンでも一定の接種直後死亡記録は発生します。 https://www.ajpmonline.org/article/S0749-3797(13)00225-0/fulltext また条件が違うとはいえ新型インフルワクチンでも同様の頻度の疑い報告が発生しています。 https://www.yakuji.co.jp/entry21054.html
Note Ratings
rated at | rated by | |
2024-10-30 18:06:16 -0500 | Rating Details | |
2024-10-30 16:29:59 -0500 | Rating Details | |
2024-10-30 15:00:46 -0500 | Rating Details | |
2024-10-30 08:59:29 -0500 | Rating Details | |
2024-10-30 02:34:43 -0500 | Rating Details | |
2024-10-30 01:10:06 -0500 | Rating Details | |
2024-10-30 00:18:49 -0500 | Rating Details | |
2024-10-29 23:48:05 -0500 | Rating Details | |
2024-10-29 23:28:20 -0500 | Rating Details | |
2024-10-29 23:15:52 -0500 | Rating Details | |
2024-10-29 22:38:17 -0500 | Rating Details | |
2024-10-29 22:11:00 -0500 | Rating Details | |
2024-10-29 21:15:43 -0500 | Rating Details | |
2024-10-29 20:21:10 -0500 | Rating Details | |
2024-10-29 20:18:29 -0500 | Rating Details | |
2024-10-29 20:10:35 -0500 | Rating Details | |
2024-10-29 19:46:32 -0500 | Rating Details | |
2024-10-30 21:02:38 -0500 | Rating Details | |
2024-10-29 23:47:47 -0500 | Rating Details | |
2024-10-29 23:24:14 -0500 | Rating Details | |
2024-10-29 22:19:35 -0500 | Rating Details | |
2024-10-29 21:58:04 -0500 | Rating Details | |
2024-10-29 21:11:38 -0500 | Rating Details | |
2024-10-29 20:54:19 -0500 | Rating Details | |
2024-10-29 20:38:10 -0500 | Rating Details | |
2024-10-29 20:22:26 -0500 | Rating Details | |
2024-10-29 20:16:07 -0500 | Rating Details | |
2024-10-29 20:10:06 -0500 | Rating Details | |
2024-10-29 19:38:24 -0500 | Rating Details | |
2024-10-29 19:15:48 -0500 | Rating Details | |
2024-10-30 16:34:28 -0500 | Rating Details | |
2024-10-30 04:47:23 -0500 | Rating Details | |
2024-10-30 04:42:28 -0500 | Rating Details | |
2024-10-29 20:41:30 -0500 | Rating Details | |
2024-10-30 08:28:19 -0500 | Rating Details | |
2024-10-30 02:56:38 -0500 | Rating Details | |
2024-10-30 02:18:39 -0500 | Rating Details | |
2024-10-29 22:52:59 -0500 | Rating Details | |
2024-10-29 21:56:56 -0500 | Rating Details | |
2024-10-29 21:26:42 -0500 | Rating Details | |
2024-10-29 21:08:44 -0500 | Rating Details | |
2024-10-29 20:37:29 -0500 | Rating Details | |
2024-10-29 19:37:40 -0500 | Rating Details | |
2024-10-30 19:33:48 -0500 | Rating Details | |
2024-10-30 03:36:43 -0500 | Rating Details | |
2024-10-30 01:06:34 -0500 | Rating Details | |
2024-10-30 00:22:42 -0500 | Rating Details | |
2024-10-30 00:10:06 -0500 | Rating Details | |
2024-10-29 23:13:19 -0500 | Rating Details | |
2024-10-29 22:49:28 -0500 | Rating Details | |
2024-10-29 22:40:03 -0500 | Rating Details | |
2024-10-29 22:23:50 -0500 | Rating Details | |
2024-10-29 22:06:13 -0500 | Rating Details | |
2024-10-29 21:10:55 -0500 | Rating Details | |
2024-10-29 21:00:35 -0500 | Rating Details | |
2024-10-29 20:31:00 -0500 | Rating Details | |
2024-10-29 20:04:32 -0500 | Rating Details | |
2024-10-29 20:00:43 -0500 | Rating Details | |
2024-10-29 19:59:39 -0500 | Rating Details | |
2024-10-29 19:10:54 -0500 | Rating Details |